BHCFX Holdings Information

BHCFX is a mutual fund with a total of 42 individual holdings. The top holdings are Eli Lilly and Company stock at 9.95%, Usd at 5.11%, AstraZeneca at 5.09%, Johnson & Johnson at 4.58%, and Thermo Fisher Scientific at 4.25%.

Total Holdings

Top 10 Percentage

46.07%

Asset Class

Equity

Fund Category

Health

Assets

108.65M

Forward PE Ratio

25.48

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	9.95%	13,000
2	n/a	Usd	5.11%	6,140,680
3	LON: AZN	AstraZeneca PLC	5.09%	31,000
4	JNJ	Johnson & Johnson	4.58%	22,500
5	TMO	Thermo Fisher Scientific Inc.	4.25%	10,400
6	MTD	Mettler-Toledo International Inc.	3.99%	3,800
7	GILD	Gilead Sciences, Inc.	3.48%	30,000
8	TEVA	Teva Pharmaceutical Industries Limited	3.26%	130,000
9	ISRG	Intuitive Surgical, Inc.	3.22%	8,400
10	ARGX	argenx SE	3.16%	5,200
11	ROIV	Roivant Sciences Ltd.	2.88%	125,000
12	ELAN	Elanco Animal Health Incorporated	2.84%	142,500
13	IONS	Ionis Pharmaceuticals, Inc.	2.81%	45,000
14	RDNT	RadNet, Inc.	2.79%	60,000
15	VRTX	Vertex Pharmaceuticals Incorporated	2.79%	7,500
16	INSM	Insmed Incorporated	2.72%	20,000
17	MRK	Merck & Co., Inc.	2.50%	25,000
18	GH	Guardant Health, Inc.	2.46%	32,000
19	NTRA	Natera, Inc.	2.45%	14,700
20	MDGL	Madrigal Pharmaceuticals, Inc.	2.31%	5,300
21	EW	Edwards Lifesciences Corporation	2.22%	33,300
22	IDXX	IDEXX Laboratories, Inc.	2.20%	4,700
23	WELL	Welltower Inc.	2.14%	13,000
24	BLLN	BillionToOne, Inc.	1.77%	27,000
25	TERN	Terns Pharmaceuticals, Inc.	1.54%	35,000

Showing 25 of 42 holdings

Subscribe to see the full list

Activate Now

As of Mar 31, 2026